Pharmacokinetic analysis of carboplatin and etoposide in a small cell lung cancer patient undergoing hemodialysis

Ken Takezawa, Isamu Okamoto, Masahiro Fukuoka, Kazuhiko Nakagawa

研究成果: ジャーナルへの寄稿学術誌査読

18 被引用数 (Scopus)

抄録

Cancer chemotherapy is not well established for patients on hemodialysis (HD). A 77-year-old man on HD presented with small cell lung cancer. He was treated with the combination of carboplatin and etoposide while the pharmacokinetics of the drugs were monitored. The patient showed a response with manageable toxicity and remained progression free for at least 8 months. The area under the concentration-time curve for each antitumor agent in the patient was within the therapeutic range achieved in individuals with normal renal function. Carboplatin and etoposide chemotherapy combined with HD thus allowed the drugs to achieve an appropriate area under the concentration-time curve and sufficient efficacy in a small cell lung cancer patient with chronic renal failure.

本文言語英語
ページ(範囲)1073-1075
ページ数3
ジャーナルJournal of Thoracic Oncology
3
9
DOI
出版ステータス出版済み - 9月 2008
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 呼吸器内科

フィンガープリント

「Pharmacokinetic analysis of carboplatin and etoposide in a small cell lung cancer patient undergoing hemodialysis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル